Abba Medix Group Inc.

Abba Medix Group Inc.

July 06, 2015 07:30 ET

Abba Medix Group (CSE:ABA) Signs Referral Agreement with GrowWise Health Limited

TORONTO, ONTARIO--(Marketwired - July 6, 2015) - Abba Medix Group Inc. (CSE:ABA), a purveyor of fine Canadian medical marijuana, accessories, events, and news, has signed a referral agreement with GrowWise Health Limited in which Abba's wholly owned subsidiary RedeCan Pharm will offer its medical cannabis to GrowWise Health patients. As a fully integrated, licensed medical marijuana grower and sales agent, Abba supplies Canadian medical cannabis to authorized patients under the Marihuana for Medical Purposes Regulations (MMPR).

"As Abba Medix is devoted to our patient and physician education, it is a natural fit with GrowWise," said Ray Rasouli, Abba Medix CEO. "We are extending our influence across a broad industry segment and patient and physician education is the key to a widespread acceptance of this new Canadian industry."

GrowWise Health, a healthcare company, provides educational and professional support services to MMPR-authorized medical cannabis patients.

"As the MMPR prescription fulfillment process excludes pharmacists, medical cannabis patients do not enjoy the same level of health care professional support as do other patients," said GrowWise Health CEO Harvey Shapiro. "The GrowWise Health educational initiative provides them with professional support currently absent in the MMPR regime." The GrowWise Health program is expected to overcome the significant impediments dissuading new patients and prescribing physicians from accessing or participating in the MMPR.

RedeCan Pharm will become a preferred provider to GrowWise Health with RedeCan's full offering of medical cannabis available to GrowWise Health's patients. The agreement between the two companies is non-exclusive.

About Abba Medix Group

Abba Medix Group Inc. (CSE:ABA) is a purveyor of fine Canadian medical marijuana, accessories, events and news. The Company is becoming a marketplace leader through strategic partnerships, mergers, and acquisitions to create a fully-integrated, Canadian medical marijuana marketplace. Abba's mission is to find and acquire strong marijuana related businesses, product companies, organizational event sponsorships, and research and development opportunities.

Through the pending acquisition of RedeCan, Abba is a licensed medical marijuana grower and sales agent, authorized to supply Canadian patients.

Through Blow Vapor, Abba is providing customers with nothing but the best, most innovative products on the market, offering a wide collection of premium products to fit everyone's lifestyle and vaping preferences.

For more information on the Abba Medix Group, please visit To shop RedeCan's medical marijuana strains, visit To shop for the perfect vape at Blow Vapor, visit

Cautionary Statements Regarding Forward-Looking Information

Certain statements within this press release relating to the Company constitute "forward-looking statements", within the meaning of applicable securities laws, including without limitation, statements regarding future estimates, business plans and / or objectives, sales programs, forecasts and projections, assumptions, expectations, and/or beliefs of future performance, are "forward-looking statements". Such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements. Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including production and / or sales of medical marijuana, quantities of future medical marijuana production, anticipated revenues in connection with such sales, the overall projected size of the market, completion and / or expansion of production facilities, and other information that is based on forecasts of future results, estimates of production not yet determinable, and other key management assumptions. Actual results may differ materially from those expressed or implied by such forward-looking statements and involve risk and uncertainties relating to the Company's historical experience with regulatory changes, timeliness of government approvals for the granting of permits and licenses, changes in medical marijuana prices, actual operating performance of facilities, and other uninsured risks. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

Contact Information

  • Abba Medix Group Inc.
    Ahmad (Ray) Rasouli
    Chief Executive Officer
    (905) 492-9420